BioXcel
The AI engine Fit Assessment
BetaBioXcel Corporation effectively utilizes machine learning and AI technologies to expand therapeutics and discover new patterns, while also engaging in drug repurposing initiatives.
Blurb
BioXcel Corporation is a biotechnology firm using big data analytics and machine learning for drug development.
HQ Location
United States
Founded
2005
Employees
51 - 200
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
Operator of a biopharmaceutical firm intended to improve the clinical and regulatory success of drug development. The company utilizes artificial intelligence and big data analytics to advance the wave of medicines by developing medicines in immuno-oncology, neuroscience and rare diseases with high unmet needs, enabling clients to impact pharma productivity and innovation to benefit the entire healthcare ecosystem.